The AJMC® Migraine compendium is a comprehensive resource for clinical news and expert insights for the recurring type of headache, which is accompanied by side effects.
April 20th 2023
This quantitative and qualitative analysis highlights differences in prior authorization requirements for migraine drugs from nearly 50 managed care organizations and summarizes broad types of criteria used.
Patients Using Medication for Migraine Still Have Unmet Treatment Needs, Survey Says
May 15th 2019In a large survey of patients with migraine taking an oral, acute prescription migraine medication, most had unmet needs, according to survey results presented recently at the annual meeting of the American Academy of Neurology.
Read More
Study Suggests Benefit to Integrating Care for Migraine, Depression
May 11th 2019A recent study examined associations of comorbid migraine with other painful physical symptoms in patients with major depressive disorder at 2 years, and results suggested there might be benefit to integrating care for those with both depression and headache.
Read More
Demographics, Characteristics of Youth Receiving Migraine Treatment at Infusion Center
April 27th 2019A retrospective chart review examining demographic characteristics of children and adolescents receiving infusions at an outpatient center for prolonged headache found that their migraines were more disabling and resulted in lower quality of life than those who did not seek treatment at a center.
Read More
Study Calls for More Effective Prophylactic Treatments for Migraine
April 25th 2019A recent retrospective study looked to evaluate long-term treatment patterns in patients with migraine initiating prophylactic therapy, as well as acute medication use and adverse events associated with opioids.
Read More